Miller R L, Webster M E, Melmon K L
Eur J Pharmacol. 1975 Aug;33(1):53-60. doi: 10.1016/0014-2999(75)90137-5.
Leukocytes can generate a substance that, when added to some partially purified human kininogen, is capable of forming kinins. The addition of endotoxin or polystyrene latex particles to the incubated leukocytes doubled the amount of kinin generated. Certain preparations of kininogen, however, failed to allow kinin formation by the leukocytes. No evidence could be found that an activator of prekallikrein or a kallikrein was present in the granulocyte preparations. However, the addition of highly purified plasminogen to inactive kininogen preparations restored their ability to generate kinins in the presence of leukocytes. All the kininogen preparations that allowed kinin formation when incubated with leukocytes contained plasminogen. These data suggest that a plasminogen activator is present on the leukocyte surface. This activator activates plasminogen to form plasmin which in turn acts on kininogen to release a kinin and thus provides a mechanism for the formation of kinins in inflammatory exudates and during endotoxemia.
白细胞能够产生一种物质,当将其添加到某些部分纯化的人激肽原中时,能够形成激肽。向内毒素或聚苯乙烯乳胶颗粒孵育的白细胞中添加物质,可使激肽生成量增加一倍。然而,某些激肽原制剂无法使白细胞形成激肽。在粒细胞制剂中未发现有前激肽释放酶激活剂或激肽释放酶存在的证据。然而,向无活性的激肽原制剂中添加高度纯化的纤溶酶原,可恢复其在白细胞存在时产生激肽的能力。所有与白细胞一起孵育时能形成激肽的激肽原制剂都含有纤溶酶原。这些数据表明,白细胞表面存在纤溶酶原激活剂。这种激活剂激活纤溶酶原形成纤溶酶,纤溶酶进而作用于激肽原释放激肽,从而为炎症渗出液和内毒素血症期间激肽的形成提供了一种机制。